{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:02:51Z","timestamp":1785934971383,"version":"3.56.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122722","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T17:52:46Z","timestamp":1429206766000},"page":"e0122722","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antipsychotic-Like Effect of the Muscarinic Acetylcholine Receptor Agonist BuTAC in Non-Human Primates"],"prefix":"10.1371","volume":"10","author":[{"given":"Maibritt B.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie Hughes","family":"Croy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Dencker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Werge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Bymaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fink-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1749-6632.1957.tb40764.x","article-title":"The inhibition of the conditioned response and counteraction of schizophrenia by muscarinic stimulation of the brain","volume":"66","author":"CC Pfeiffer","year":"1957","journal-title":"An NY Acad Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00710912","article-title":"Central cholinergie blockade of the conditioned avoidance response in rats","volume":"6","author":"R Chalmers","year":"1964","journal-title":"Psychopharmacologia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(99)00138-3","article-title":"Xanomeline, an M1\/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice","volume":"42","author":"HE Shannon","year":"2000","journal-title":"Schizophr Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.npp.1300151","article-title":"The muscarinic M1\/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys","volume":"28","author":"MB Andersen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","author":"NC Bodick","year":"1997","journal-title":"Archives of neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"A Shekhar","year":"2008","journal-title":"Am J Psychiatry"},{"key":"ref7","first-page":"109","article-title":"Unexpected antipsychotic-like activity with the muscarinic receptor ligand \u017e 5 R, 6 R \/ 6- \u017e 3-propylthio-1, 2, 5-thiadiazol-4-yl \/ -1-azabicyclo w 3","author":"FP Bymaster","year":"1998","journal-title":"2. 1 x octane"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(00)00129-8","article-title":"The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance","volume":"49","author":"T Rasmussen","year":"2001","journal-title":"Schizophr Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.104.075887","article-title":"Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats","volume":"312","author":"CK Jones","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref10","first-page":"2717","article-title":"Neuropsychopharmacology","volume":"38","author":"ML Watt","year":"2013"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0022-3565(24)38222-9","article-title":"Vandergriff a, Falcone J, McClure D, et al. Determination of [35S]guanosine-5\u2019-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay","volume":"289","author":"NW DeLapp","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref12","first-page":"4378","article-title":"Muscarinic Agonists with Antipsychotic-like Activity : Structure\u2014Activity Relationships of 1, 2, 5-Thiadiazole Analogues with Functional Dopamine","author":"P Sauerberg","year":"1998","journal-title":"Muscarinic Agonists with Antipsychotic-like Activity\u202f: Structure\u2014Activity Relationships of 1, 2, 5-Thiadiazole Analogues with Functional Dopamine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002130050993","article-title":"New and old antipsychotics versus clozapine in a monkey model: Adverse effects and antiamphetamine effects","volume":"144","author":"L Peacock","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0893-133X(98)00049-9","article-title":"Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: Antiamphetamine effects and extrapyramidal side effects","volume":"20","author":"L Peacock","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0024-3205(98)00597-9","article-title":"Potential role of muscarinic receptors in schizophrenia","author":"FP Bymaster","year":"1999","journal-title":"Life Sciences"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-009-1740-z","article-title":"Modulation of prepulse inhibition through both M1 and M 4 muscarinic receptors in mice","volume":"208","author":"M Thomsen","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1523\/JNEUROSCI.0370-11.2011","article-title":"Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1\/M4 preferring muscarinic receptor agonist xanomeline","volume":"31","author":"D Dencker","year":"2011","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-012-2751-8","article-title":"An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine","volume":"224","author":"D Dencker","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","article-title":"Domperidone: Review of pharmacology and clinical applications in gastroenterology","volume":"102","author":"SC Reddymasu","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1124\/jpet.108.140350","article-title":"Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats","volume":"327","author":"AE Brady","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/npp.2014.2","article-title":"Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100","volume":"39","author":"NE Byun","year":"2014","journal-title":"Neuropsychopharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T17:06:55Z","timestamp":1747933615000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122722"}},"subtitle":[],"editor":[{"given":"Maurice","family":"Ptito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122722","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}